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Abstract: Rickettsiae may cause febrile infections in humans in tropical and subtropical regions.
From Madagascar, no molecular data on the role of rickettsioses in febrile patients are available.
Blood samples from patients presenting with fever in the area of the capital Antananarivo were
screened for the presence of rickettsial DNA. EDTA (ethylenediaminetetraacetic acid) blood from
1020 patients presenting with pyrexia > 38.5 ◦C was analyzed by gltA-specific qPCR. Positive samples
were confirmed by ompB-specific qPCR. From confirmed samples, the gltA amplicons were sequenced
and subjected to phylogenetic analysis. From five gltA-reactive samples, two were confirmed by
ompB-specific qPCR. The gltA sequence in the sample taken from a 38-year-old female showed 100%
homology with R. typhi. The other sample taken from a 1.5-year-old infant was 100% homologous to
R. felis. Tick-borne rickettsiae were not identified. The overall rate of febrile patients with molecular
evidence for a rickettsial infection from the Madagascan study site was 0.2% (2/1020 patients). Flea-
borne rickettsiosis is a rare but neglected cause of infection in Madagascar. Accurate diagnosis may
prompt adequate antimicrobial treatment.
Keywords: Rickettsia typhi; Rickettsia felis; Madagascar; flea-borne rickettsiosis; murine typhus
1. Introduction
Rickettsiae are arthropod-borne, obligate intracellular Gram-negative bacteria. Phy-
logenetically, they are divided into four groups: the largely tick-associated spotted fever
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group that encompasses >25 species (e.g., Rickettsia [R.] rickettsii, R. africae), the lice-/flea-
associated typhus group (e.g., R. typhi), the transitional group (e.g., R. felis, which is
flea-associated) and the tick-associated ancestral group (e.g., R. bellii) [1,2].
Some, but not all rickettsiae harbored by arthropods are well-known human pathogens,
and their pathogenicity differs from species to species. R. rickettsii, the agent of Rocky
Mountain spotted fever (RMSF), is endemic in the Americas and is transmitted by ticks of
the genera Dermacentor and Rhipicephalus. RMSF is probably the most lethal rickettsiosis,
with a case-fatality rate of >35% when treatment with doxycycline is delayed [3]. In
Brazil, mortality of RMSF may exceed 50% in some clusters [4]. On the African continent,
entomological studies have confirmed the presence of rickettsial DNA in several different
tick and flea species [5–7]. R. africae, which infests Amblyomma ticks to a percentage of
>90%, is the causative agent of African tick-bite fever (ATBF). ATBF is often reported in
travelers to Sub-Saharan Africa and usually manifests as a benign disease [8].
Fleas are typical vectors for R. typhi and R. felis. While R. typhi is mainly found in the
rat flea Xenopsylla (X.) cheopis, R. felis has been detected in several flea species, including
the cat flea Ctenocephalides felis, X. cheopis and the human flea Pulex irritans [6]. Molecular
studies from Northern Africa have reported clinical cases of murine typhus [9,10]. Seroepi-
demiological reports from Sub-Saharan Africa suggest that up to 11% of the population
are exposed to R. typhi, e.g., in Mali [11,12]. The mortality of murine typhus is very low
(<1%) [13]. R. felis was identified as a potential cause of febrile illness in 1-15% of patients
with fever from some African countries, e.g., Ghana and Senegal [14,15]. However, R. felis
has also been found in blood samples of non-febrile control subjects, albeit at a significantly
lower rate than in febrile patients [16,17]. Consequently, there is some controversy about
the pathophysiology of R. felis infections and its role as an obligatory pathogen.
Clinically, spotted fever group rickettsioses often present with fever and an efflores-
cence called “eschar”, a cutaneous ulcerative lesion at the site of tick bite [18]. Typhus
group rickettsioses such as murine typhus (R. typhi) and epidemic typhus (R. prowazekii)
are not associated with eschar formation and are thus more difficult to diagnose. Murine
typhus presents with a “classical” triad of fever, headache and rash, which is encountered
in 33% of patients [19]. R. felis has been associated with similar symptoms as murine
typhus [14,20].
Until recently, the importance of rickettsial infections in Madagascar has remained
largely unknown. High percentages of Amblyomma variegatum (86.5%) and Amblyomma
chabaudii ticks (100%) were found to be infested with Rickettsia (R.) africae [7,21]. Xenopsylla
cheopis fleas, collected from small mammals in urban Malagasy areas, tested positive for
R. typhi and R. felis, while Pulex irritans fleas from the same area were positive for R. felis [6].
Although it was shown that humans carry antibodies against both typhus group (TG)
and spotted fever group (SFG) rickettsiae [6,21], direct molecular evidence for rickettsial
infections in humans from Madagascar is so far lacking. A recent pan-Madagascan study
that enrolled 682 febrile patients failed to detect rickettsial DNA by applying a novel
macroarray system [22]. Here, we present the results of a real-time PCR-based screening
for rickettsial DNA in EDTA blood of febrile patients from Madagascar.
2. Results
The patient population, a subset from the Typhoid Fever Surveillance in Africa Pro-
gram (TSAP) study, was previously characterized in detail by Boone et al. [23]. Briefly,
1020 samples from patients living in a rather rural environment (Imerintsiatosika) or in
urban slums (Isotry, central Antananarivo) and presenting with pyrexia ≥38.5 ◦C were
selected for the present study. From 1,020 EDTA samples screened for rickettsial DNA
by gltA-specific qPCR, five samples showed amplification in at least one of two replicate
runs. Of those, 2/5 samples (#4133, #4196) were confirmed by repeated testing using the
same target.
To identify the rickettsial species, gltA amplicons were sequenced applying Sanger
sequencing. Excluding primer regions, a sequence of 116 bp was analyzed (for gltA
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sequences, see Tables A1 and A2). The two positive samples differed in nine positions.
Compared to published sequences in the NCBI database, the gltA amplicon of sample
#4133 showed 100% homology to several reference strains of R. typhi, while sample #4196
showed 100% homology to R. felis. The phylogenetic analysis, which included other closely
related Rickettsia species, confirmed this identification (Figure 1).
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A larger ompB amplicon could not be obtained from sample #4196. Instead, we utilized
the intergenic spacer-typing approach by Fournier et al. to confirm the gltA sequencing
result [25]. The two intergenic spacers dksA-xerC (amplicon size: 164 bp, see Table A2) and
rpmE-tRNAfMet (amplicon size: 351 bp, GenBank OL310471) were successfully sequenced
from sample #4196. Both showed 100% homology with R. felis. The identification of the
rickettsial species in sample #4196 as R. felis was further confirmed by a R. felis-specific
ompB qPCR [26] (Table 1).
Both patients with molecular confirmation of Rickettsia spp. in their blood samples
were from the urban study site in Antananarivo. The R. typhi patient was a 38-year-old
female from the Manarintsoa-Isotry district in central Antananarivo, while the R. felis
patient was a 17-month-old infant from Antohomadinika Sud, another central area in
Antananarivo. In both individuals, a fever of > 39 ◦C and a cough were noted, but no rash
(Table 1).
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Table 1. Detection of Rickettsia DNA: sample and patient characteristics.
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1 NP = not possible. Ct = cycle threshold, y = year, m = month, ID = identification number, temp. = temperature, R. = Rickettsia,
Rick. = Rickettsia spp.
These results provide a molecular confirmation of human-pathogenic rickettsiae for
the first time in febrile patients from Madagascar. Only the flea-borne species R. typhi and
R. felis were found; no tick-borne rickettsiae were identified. Overall, the positive rate for
Rickettsia spp. DNA in febrile patients was 0.2% (2/1020 patients) in this study.
3. Discussion
The high endemicity of plague in Madagascar indicates that the Malagasy population
is exceptionally exposed to flea-borne infections [27,28]. However, little is known about the
regional epidemiology of flea-borne rickettsioses. Apart from a single case of an R. typhi
infection in a French traveler returning from Madagascar [29], there has only been indirect
serological evidence that humans may become infected [6]. Molecular data from fleas that
showed infection with rickettsiae suggested that there might be a risk of transmission to
humans [6]. The present study shows for the first time, based on a real-time PCR screening
for rickettsial DNA in febrile patients, that human-pathogenic, flea-borne rickettsiae are
transmitted to humans in Madagascar.
Overall, the detection rate of rickettsial DNA in whole blood samples was low in this
study (2/1020 patients). While we cannot exclude that storage and transport conditions may
have affected the stability of target DNA in our study, previous investigations showed that
Rickettsia-specific PCRs from blood samples may yield false-negative results in serologically
confirmed cases [30,31]. A systematic review reported a blood DNA median sensitivity
of 18% (6–27%) for pan-Rickettsia PCRs (SFG: 42% [6–69%]; TG: 3% [1–18%]) [32]. Thus,
we may have missed some rickettsial infections by our approach. Importantly, the high Ct
values identified here should not be interpreted as a sign of low clinical relevance, since
they reflect the transient nature of these pathogens in circulating blood [33]. In sum, it
is likely that the actual number of rickettsial infections among febrile patients may be
several-fold higher than that detected by PCR.
With 1/1020 samples (0.1%) testing positive for R. felis, the detection rate in the urban
setting of the Malagasy capital is lower than previously reported from continental African
countries, where frequencies from 1.5% PCR-positive samples in Ghana to 15% in rural
Senegal have been found [14,15]. As in our 1-year- and 5-month-old patients, R. felis
is thought to be a common cause of febrile disease in children [14]. It can be detected
significantly more often in febrile compared to afebrile patients, but its identification in
afebrile pediatric control groups [16,34] has questioned its role as an obligatory pathogen.
Another conundrum is the significance of Plasmodium falciparum/R. felis co-infections in
regions with high malaria endemicity [14,15]. Notably, in our Malagasy study population,
malaria was found only in a very low percentage of febrile patients (0–2%) [35].
R. typhi causes murine typhus, an infection with low mortality, and is transmitted
worldwide, mainly in suburban areas [36]. Epidemiological studies indicate its transmis-
sion to humans in African countries [11,12,37], and direct molecular evidence from fever
studies has primarily been provided from the northern African countries Algeria and
Tunisia [38].
Infections with R. typhi and R. felis are associated with similar clinical presentations.
Distinguishing them is possible by molecular diagnostics [26,39], but difficult by serology.
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In both infections, typical symptoms include fever and cough, as in our patients, and the
absence of rashes often complicates the clinical diagnosis [14,36].
The present study found no evidence for spotted fever group rickettsiae in febrile
patients. While according to seroprevalence studies, transmission of SFG rickettsiosis
occurs in Madagascar [21], these infections are likely to only rarely present as bloodstream
infections and may therefore be difficult to diagnose by applying molecular diagnostic
approaches with EDTA blood samples.
While it was not determined in the present study whether fleas from the specific
patients’ areas of residence carry R. felis or R. typhi, a similar study was performed in urban
areas of the Tsiroanomandidy district, about 200 km west of Antananarivo. Here, 26/117
(24%) Xenopsylla cheopis fleas collected from small mammals tested positive for R. typhi, and
2/117 (2%) were positive for R. felis. In 8/26 (31%) Pulex irritans fleas, R. felis was detected.
No co-infections with both species in the same flea were reported. It is highly likely that
rodents in Antananarivo carry fleas with a similarly high proportion of Rickettsia infection,
thus posing a risk for transmission of R. felis and R. typhi to humans.
In future research, a prospective study design may be appropriate when investigating
rickettsial infections in Madagascar. A comprehensive approach that takes into account
clinical clues for rickettsial infections (e.g., eschars or rashes), serological assays (e.g.,
IgM/IgG against several rickettsial antigens) and immediate sample processing for PCR
(e.g., from buffy coat) may provide a more complete picture of spotted and typhus fever
rickettsioses.
4. Materials and Methods
4.1. Human Blood Sample Collection
EDTA blood samples were collected within the framework of the Typhoid Fever
Surveillance in Africa Program (TSAP) [40]. A detailed description of how samples were
collected is provided elsewhere [23]. In brief, 4500 EDTA blood specimens were collected
from febrile patients in Madagascar between 2011 and 2013 continuously throughout the
year. Of those, a total of 1,020 samples from individuals presenting with a body temperature
≥38.5◦C were screened for the presence of rickettsial DNA. Samples were previously tested
for the presence of Burkholderia pseudomallei, Coxiella burnetii, Brucella spp., Leptospira spp.
and Borrelia spp. DNA, with a detection rate of 1.5% for Brucella spp. and otherwise
negative results [23,41].
4.2. DNA Extraction and Real-Time PCR
Total DNA was extracted from 1 ml of human EDTA blood samples using the Flexigene
DNA Kit (Qiagen, Hilden, Germany), following the manufacturer’s protocol. Rickettsial DNA
was screened for by gltA-specific real-time PCR, using a modification of a previously published
protocol based on the primers RKND03_F (5′-GTGAATGAAAGATTACACTATTTAT-3′) and
RKND03_R (5′-GTATCTTAGCAATCATTCTAATAGC-3′), which yields an amplicon of 166 bp
(base pairs) [42,43]. In a total of 10 µL, reactions contained 1x reaction buffer (Invitrogen,
Darmstadt, Germany), 2.5 mM magnesium chloride, 0.2 mM deoxynucleotides (ABI), 5 nM
bovine serum albumin, 0.5 µM of each oligonucleotide (Tibmolbiol, Berlin, Germany), SYBR
Green, 0.25 U PlatinumTaq DNA polymerase and 2 µL of sample. Reactions were run in
duplicate on a LightCycler 480 II instrument (Roche, Mannheim, Germany). The following
cycling conditions were used: activation 95 ◦C, 15 min; 45 cycles: denaturation 94 ◦C, 15 s;
annealing 60 ◦C, 30 s; elongation 72 ◦C, 30 s.
When a typical amplification curve was found, the result was confirmed in two
independent, ompB-specific real-time PCRs for R. typhi and R. felis that allow detection of
each species by a molecular beacon [26]. Samples showing amplification in both gltA and
ompB assays were interpreted as positive for Rickettsia spp.
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4.3. Conventional PCR, Sequencing and Phylogenetic Analysis
For further typing, the intergenic spacer dksA-xerC was amplified using the primers
dksA-xerC_F (5′-TCCCATAGGTAATTTAGGTGTTTC-3′) and dksA-xerC_R (5′-
TACTACCGCATATCCAATTAAAAA-3′ [25]). The spacer rpmE-tRNAfMet was ampli-
fied using the primers rpmE-tRNArMet_F (5′-TTCCGGAAATGTAGTAAATCAATC-3′)
and tRNArMet_F (5′-TCAGGTTATGAGCCTGACGA-3′ [25]). For sequencing a part of
the ompB gene, the primers 120-M59 (5′-CCGCAGGGTTGGTAACTGC-3′) and 120-807
(5′-CCTTTTAGATTACCGCCTAA-3′ [24]) were used.
All conventional PCR reactions were run on a GeneAmp PCR System 2700 thermo-
cycler (ABI) in a total volume of 50 µL, in the presence of 1x reaction buffer (Invitrogen,
Darmstadt, Germany), 1.5 mM magnesium chloride, 0.2 mM deoxynucleotides (ABI),
0.2 µM of each oligonucleotide (Tibmolbiol, Berlin, Germany), 2 U PlatinumTaq DNA
polymerase and 2 µL of sample. Upon denaturation at 95 ◦C for 3 min, 40 PCR cycles of
30 s at 95 ◦C, 30 s at 54 ◦C (spacers) or 58 ◦C (ompB) and 1 min at 72 ◦C were run, followed
by a 5 min extension at 72 ◦C.
The gltA, ompB, dksA-xerC and rpmE-tRNAfMet amplicons were visualized by agarose
gel electrophoresis and subjected to bidirectional conventional Sanger sequencing (Seqlab,
Göttingen, Germany). Sequences <200 bp are provided in Appendix A (Tables A1 and A2);
sequences > 200 bp were deposited in the NCBI GenBank under the accession numbers
OL310470 (ompB) and OL310471 (rpmE-tRNAfMet).
Upon Clustal W multiple alignment (BioEdit Sequence Alignment Editor, version
7.0.5.3), gltA sequences were analyzed phylogenetically using the MEGA7 software (Molec-
ular Evolutionary Genetics Analysis version 7.0 for bigger datasets; Kumar, Stecher, and
Tamura 2015).
5. Conclusions
Taken together, the present study provides direct molecular evidence for both R. typhi
and R. felis in blood samples of febrile patients from Madagascar. We suggest that flea-borne
rickettsial infections are a relevant differential diagnosis of fevers of unknown etiology
in a small number of patients and should be considered when deciding on empirical
antimicrobial therapy by healthcare professionals in Madagascar.
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Appendix A. Sequences Obtained in the Study
Table A1. Supplementary sequence information, sample #4133.
#4133, gltA (116 bp)
TTCAAACCTTTTGTAGTTCTTCTCATCCTATGGCTATTATGCTTGCAGCTGTT
GGTTCTCTTTCAGCATTTTATCCTGATTTATTGAATTTTAATGAAACAGACTATGAACTTACC
#4133, ompB (759 bp): GenBank accession number OL310470
Table A2. Supplementary sequence information, sample #4196.
#4196, gltA (116 bp)
TTCAAACATTTTGTAGCTCTTCTCATCCTATGGCTATTATGCTTGCGGCCGTT
GGTTCTCTTTCGGCATTTTATCCTGATTTACTGAATTTTAAAGAAGCAGACTACGAACTTACC
#4196, dksA-xerC (117 bp)
TAGCATATTAATATCTCAATATTAGCTTTAGTATATTATGTTTATAAGGTTTTTAAAA
TAAAATAATATATAACTTAAAACTAACGCAAGAAGATTATGAATATTAATATATTTTAT
#4196, rpmE-tRNAfMet (319 bp): GenBank Accession number OL310471
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